cefotetan has been researched along with Female Genital Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Estes, JM; Kendrick, JE; Kimball, KJ; Leath, CA; Numnum, TM; Straughn, JM | 1 |
| Consonni, R; Landoni, F; Mangioni, C; Regallo, M; Scalambrino, S | 1 |
1 trial(s) available for cefotetan and Female Genital Neoplasms
| Article | Year |
|---|---|
Antibiotic prophylaxis of infection after gynecologic surgery: a prospective randomized trial between cefotetan and piperacillin.
Topics: Cefotetan; Clinical Trials as Topic; Female; Genital Neoplasms, Female; Humans; Hysterectomy; Middle Aged; Piperacillin; Postoperative Complications; Prospective Studies; Random Allocation; Surgical Wound Infection | 1987 |
1 other study(ies) available for cefotetan and Female Genital Neoplasms
| Article | Year |
|---|---|
Conservative management of postoperative Fever in gynecologic patients undergoing major abdominal or vaginal operations.
Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Cefotetan; Fallopian Tubes; Female; Fever of Unknown Origin; Follow-Up Studies; Genital Neoplasms, Female; Humans; Hysterectomy; Middle Aged; Observation; Ovariectomy; Patient Readmission; Postoperative Complications; Prospective Studies; Risk Factors | 2008 |